About this trial
This feasibility study aims to assess interest, recruitment, and adherence to a supervised physical activity (APA) program among individuals with Alcohol Use Disorder (AUD). It also investigates the program's impact on sleep quality and efficiency. Key objectives include evaluating recruitment feasibility, assessing randomization acceptance, quantifying adherence rates, and identifying sensitive sleep assessment tools. The study will explore whether APA improves sleep outcomes in AUD patients with sleep complaints, laying groundwork for larger-scale research.
Participants will engage in APA sessions, complete sleep assessments (including sleep diaries and psychometric scales), and provide sociodemographic data and past activity adherence.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Subjects aged 18 to 65 years inclusive
Present an Alcohol Use Disorder (AUD) with at least 2 positive items as defined by the DSM-5
Present a sleep complaint with a score on the Pittsburgh Sleep Quality Index (PSQI) ≥ 5
Present active alcohol consumption with at least 6 days of excessive alcohol consumption in the last 4 weeks
Disqualifiers
Decompensated heart failure
Complex ventricular arrhythmias
Severe uncontrolled hypertension
Pulmonary hypertension (>60 mmHg)
Trial design
Parallel
Treatments tested in this trial
APA managed by qualified instructor
BehavioralEach session will be led by a qualified APA professional and will include a mix of aerobic, anaerobic, and 'mind-body' activities like yoga, tailored to participant preferences. Intensity will range from moderate to vigorous, with activities such as walking, cycling, and club-based exercises for at least 20 minutes per session. Participants will be progressively involved in session planning to support continued practice post-study. Heart rate monitoring will be used during exercises like the 6-minute walk test and chair rise test, while a daily activity calendar will help ensure adherence, documenting session dates, durations, subjective intensity, and activity type.
Autonomous APA
BehavioralA leaflet highlighting the importance of non-sedentary behavior according to WHO recommendations will be provided to them. They will have the opportunity to engage in physical activity autonomously according to their preference.
Treatment groups
Trial outcomes
Primary outcomes
Sleep duration measured by actigraphy.
Objective measurement of sleep duration (in minutes) using actigraphy over the course of the study.
Circadian parameters measured by urinary melatonin levels.
Levels of urinary melatonin (in ng/mL) assessed as an indicator of circadian rhythm.
Sleep quality assessed by Pittsburgh Sleep Quality Index (PSQI).
Subjective sleep quality measured using the PSQI, a validated scale ranging from 0 (better quality) to 21 (poor quality).
Insomnia severity measured by Insomnia Severity Index (ISI).
Evaluation of insomnia severity using ISI, a composite scale ranging from 0 (no clinically significant insomnia) to 28 (severe insomnia).
Secondary outcomes
Alcohol Consumption
Daily alcohol consumption reported in standard units (equivalent to 10g of alcohol) using the Timeline Follow Back (TLFB) method.
Direct Markers of Alcohol Use
Biological markers directly indicating alcohol consumption.
Indirect Markers of Alcohol Use
Biological markers indirectly indicating alcohol consumption.
Alcohol Dependence (ADS-Fr Score)
Alcohol dependence evaluated using the French version of the Alcohol Dependence Scale (ADS-Fr).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.